Talking it out: study tests 'Remission' consultation for breast cancer patients
NCT ID NCT02740491
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a special 'remission' consultation with a psychotherapist can improve quality of life for women who have finished treatment for localized breast cancer. Fifty women who completed chemotherapy or radiotherapy in the last six months were offered this talk. Researchers tracked their quality of life, body image, and psychological distress at 3, 6, and 12 months after the consultation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Remission consultation with a psychotherapist
- What this could lead to
- If it works, this could show that a structured psychological consultation after breast cancer treatment helps improve quality of life and body image.
- What could go wrong
- This is a small, completed study with only 50 participants and no control group, so results may not be generalizable. The intervention is a single consultation, which may have limited impact.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
50 people
The number who actually took part.
- Started
-
Sep 2016
- Finished
-
Oct 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of adult patients diagnosed with localized breast cancer who have completed adjuvant treatment (chemotherapy, radiotherapy) and who are cared for in the Medical Oncology department of the Nîmes University Hospital.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The patient is receiving care for localized breast cancer and finished her adjuvant treatment (chemotherapy, radiotherapy) * The patient has completed his/her adjuvant therapy in the last 6 months (chemotherapy, radiotherapy). Exclusion Criteria: * The patient is participating in another study * The patient is under judicial protection * It is impossible to correctly inform the patient * The patient has a metastatic form of the disease at diagnosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast neoplasms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can dancing ease the exhaustion of breast cancer treatment?
- AI reads tumor slides to match cancer patients with trials
- Lung imaging could reveal the best anesthetic dose for breast surgery
- Can a Dual-Target drug crack resistant gynecologic and breast cancers?
- AI turns routine chest scans into breast cancer detector
- One shot of radiation: can a single dose replace weeks of breast cancer treatment?